Evofem Biosciences, Inc. (EVFM) Financials

EVFM Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 10.6 million 77.1 million
2023-09-30 13.3 million 67.9 million
2023-06-30 14.1 million 69.7 million
2023-03-31 25.2 million 97.0 million

EVFM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -170000 246000
2023-09-30 -2.4 million 258000
2023-06-30 -1.5 million 268000
2023-03-31 -6.6 million 183000

EVFM Net Income

No data available :(

EVFM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 105000
2023-09-30 -151000 - 151000
2023-06-30 19.9 million - 195000
2023-03-31 2.8 million - 4.9 million

EVFM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 20.0 million
2023-09-30 4.2 million
2023-06-30 1.6 million
2023-03-31 896746

EVFM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 1.4 million 5.9 million -
2023-09-30 - 614000 3.2 million 3.0 million
2023-06-30 1000 402000 4.9 million 2.2 million
2023-03-31 35000 1.7 million 3.2 million 7.0 million

EVFM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 4.8 million 954000
2023-09-30 5.1 million 1.9 million
2023-06-30 2.5 million 2.3 million
2023-03-31 181000 384000

EVFM

Price: $0.01

52 week price:
0.01
4.38

Earnings Per Share: 38.97 USD

P/E Ratio: -0.02

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 2.6 million

Ebitda: -1.8 million

Market Capitalization: 769486

Links: